FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3206683849> ?p ?o ?g. }

• W3206683849 abstract "Abstract Background The presence of acute kidney injury in the setting of acute heart failure (AHF) or acute decompensated heart failure (ADHF) is very common occurrence and was termed cardiorenal syndrome 1 (CRS1). Neutrophil gelatinase-associated lipocalin (NGAL) in the blood and urine is one of the earliest biomarkers of acute kidney injury due to ischemia or renal toxicity. Cystatin C is early marker of renal dysfunction. NT-proBNP is valuable in the diagnosis, prognosis and treatment of acute and chronic heart failure. This study was aimed to evaluate the diagnostic efficacy of the combination of plasma NGAL, Cystatin C and NT-proBNP in diagnosis of CRS1. Methods There were 139 patients with AHF or ADHF in the department of Cardiovascular resuscitation and Interventional cardiology at Ho Chi Minh City 115 People Hospital from November 2018 to May 2019. This was a prospective cohort study. Results There were 48 cases (rate 34.5%) with CRS1, mean age 66.12±15.77, men accounted for 50.4%. There were no significant differences of vital signs on admission, diagnosis, type of heart failure between CRS1 and Non-CRS1 groups. The urea, creatinin on first day (creatininD1) and third day (creatininD3), NT-proBNP, Cystatin C, NGAL levels were higher in the group with CRS1 than Non-CRS1, the difference was statistically significant p&lt;0.05. The optimal cut-off NGAL for diagnosing CRS1 was &gt;353.23 ng/ml, Area Under Curve (AUC) was 0.732 (95% CI 0.65–0.80, p&lt;0.001), sensitivity 74.47%, specificity 68.48%, positive predictive value 54.7%, negative predictive value 84%. The optimal cut-off Cystatin C for diagnosing CRS1 was &gt;1.81 mg/dl, AUC was 0.787 (95% CI 0.71–0.85, p&lt;0.001), sensitivity 75%, specificity 83.52%, positive predictive value 70.6%, negative predictive value 86.4%. The optimal cut-off NT-proBNP for diagnosing CRS1 was 17681 pg/ml, AUC was 0.683 (95% CI 0.59 – 0.76, p&lt;0.001), sensitivity 53.19%, specificity 77.17%, positive predictive value 54.3%, negative predictive value 76.3%. Combined three biomarker plasma NGAL, Cystatin C and NTproBNP, the specificity of the diagnosis was the highest 95.6%, the positive predictive value was the highest 84.62% in diagnosing CRS1. Conclusions The combined plasma NGAL, Cystatin C and NT-proBNP is high value in the diagnosis of CRS1 in patients with AHF or ADHF. Funding Acknowledgement Type of funding sources: None." @default.
• W3206683849 created "2021-10-25" @default.
• W3206683849 creator A5013182111 @default.
• W3206683849 date "2021-10-01" @default.
• W3206683849 modified "2023-10-17" @default.
• W3206683849 title "Value of combined Plasma NGAL, Cystatin C And NT-proBNP in the diagnosis of cardiorenal syndrome type 1" @default.
• W3206683849 doi "https://doi.org/10.1093/eurheartj/ehab724.1036" @default.
• W3206683849 hasPublicationYear "2021" @default.
• W3206683849 type Work @default.
• W3206683849 sameAs 3206683849 @default.
• W3206683849 citedByCount "1" @default.
• W3206683849 countsByYear W32066838492023 @default.
• W3206683849 crossrefType "journal-article" @default.
• W3206683849 hasAuthorship W3206683849A5013182111 @default.
• W3206683849 hasConcept C126322002 @default.
• W3206683849 hasConcept C159641895 @default.
• W3206683849 hasConcept C164705383 @default.
• W3206683849 hasConcept C188816634 @default.
• W3206683849 hasConcept C2778198053 @default.
• W3206683849 hasConcept C2779295919 @default.
• W3206683849 hasConcept C2779548226 @default.
• W3206683849 hasConcept C2780472472 @default.
• W3206683849 hasConcept C2781309322 @default.
• W3206683849 hasConcept C71924100 @default.
• W3206683849 hasConcept C90924648 @default.
• W3206683849 hasConceptScore W3206683849C126322002 @default.
• W3206683849 hasConceptScore W3206683849C159641895 @default.
• W3206683849 hasConceptScore W3206683849C164705383 @default.
• W3206683849 hasConceptScore W3206683849C188816634 @default.
• W3206683849 hasConceptScore W3206683849C2778198053 @default.
• W3206683849 hasConceptScore W3206683849C2779295919 @default.
• W3206683849 hasConceptScore W3206683849C2779548226 @default.
• W3206683849 hasConceptScore W3206683849C2780472472 @default.
• W3206683849 hasConceptScore W3206683849C2781309322 @default.
• W3206683849 hasConceptScore W3206683849C71924100 @default.
• W3206683849 hasConceptScore W3206683849C90924648 @default.
• W3206683849 hasIssue "Supplement_1" @default.
• W3206683849 hasLocation W32066838491 @default.
• W3206683849 hasOpenAccess W3206683849 @default.
• W3206683849 hasPrimaryLocation W32066838491 @default.
• W3206683849 hasRelatedWork W2060761887 @default.
• W3206683849 hasRelatedWork W2401609883 @default.
• W3206683849 hasRelatedWork W2895997268 @default.
• W3206683849 hasRelatedWork W2897831938 @default.
• W3206683849 hasRelatedWork W2945237360 @default.
• W3206683849 hasRelatedWork W2954792027 @default.
• W3206683849 hasRelatedWork W2955606434 @default.
• W3206683849 hasRelatedWork W3004314209 @default.
• W3206683849 hasRelatedWork W3091351345 @default.
• W3206683849 hasRelatedWork W4377823086 @default.
• W3206683849 hasVolume "42" @default.
• W3206683849 isParatext "false" @default.
• W3206683849 isRetracted "false" @default.
• W3206683849 magId "3206683849" @default.
• W3206683849 workType "article" @default.